NDA 206163 describes LEVOTHYROXINE SODIUM, which is a drug marketed by
Teva Pharms Usa Inc,
Dr Reddys,
Fresenius Kabi Usa,
Maia Pharms Inc,
Par Sterile Products,
Piramal Critical,
Zydus Pharms,
Hikma,
Accord Hlthcare,
Amneal,
Ascent Pharms Inc,
Lupin,
Macleods Pharms Ltd,
Merck Kgaa,
Mylan, and
Watson Labs Teva, and is included in eighteen NDAs. It is available from
thirty-two suppliers. There are seven patents protecting this drug and two Paragraph IV challenges. Additional details are available on the
LEVOTHYROXINE SODIUM profile page.
The generic ingredient in LEVOTHYROXINE SODIUM is
levothyroxine sodium. There are ten
drug master file entries for this compound. Forty-eight
suppliers are listed for this compound. Additional details are available on the
levothyroxine sodium profile page.